Implementation of values-based healthcare in inflammatory bowel disease—a review

• by Patrick Hilley, Simone Chin, Darren Wong, Peter De Cruz

• September 19, 2025

Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury

• by Ruxiang Sheng, Yanqiu Liang, Huihong Zhang, Yonghe Lai, Haiyun Hong, Dingbang Huang, Dezhao Liu

• May 1, 2026

Evaluation of Tacrolimus in Ulcerative Colitis: A Retrospective Analysis of Factors Influencing Remission Induction and Maintenance

• by Ayumi Ito, Shun Murasugi, Miki Koroku, Maria Yonezawa, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige, Yousuke Nakai

• March 5, 2026

Genes Predict Bowel Disease Severity

Large study suggests genetic risk scores could help doctors identify patients who need closer monitoring and earlier treatment

• March 12, 2026

• 2 min